skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Ghia, Paolo ; Pluta, Andrzej ; Wach, Malgorzata ; Lysak, Daniel ; Kozak, Tomas ; Simkovic, Martin ; Kaplan, Polina ; Kraychok, Iryna ; Illes, Arpad ; de la Serna, Javier ; Dolan, Sean ; Campbell, Phillip ; Musuraca, Gerardo ; Jacob, Abraham ; Avery, Eric ; Lee, Jae Hoon ; Liang, Wei ; Patel, Priti ; Quah, Cheng ; Jurczak, Wojciech

Journal of clinical oncology, 2020-09, Vol.38 (25), p.2849-2861 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

Byrd, John C ; Hillmen, Peter ; Ghia, Paolo ; Kater, Arnon P ; Chanan-Khan, Asher ; Furman, Richard R ; O'Brien, Susan ; Yenerel, Mustafa Nuri ; Illés, Arpad ; Kay, Neil ; Garcia-Marco, Jose A ; Mato, Anthony ; Pinilla-Ibarz, Javier ; Seymour, John F ; Lepretre, Stephane ; Stilgenbauer, Stephan ; Robak, Tadeusz ; Rothbaum, Wayne ; Izumi, Raquel ; Hamdy, Ahmed ; Patel, Priti ; Higgins, Kara ; Sohoni, Sophia ; Jurczak, Wojciech

Journal of clinical oncology, 2021-11, Vol.39 (31), p.3441-3452 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
3
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Younes, Anas ; Sehn, Laurie H ; Johnson, Peter ; Zinzani, Pier Luigi ; Hong, Xiaonan ; Zhu, Jun ; Patti, Caterina ; Belada, David ; Samoilova, Olga ; Suh, Cheolwon ; Leppä, Sirpa ; Rai, Shinya ; Turgut, Mehmet ; Jurczak, Wojciech ; Cheung, Matthew C ; Gurion, Ronit ; Yeh, Su-Peng ; Lopez-Hernandez, Andres ; Dührsen, Ulrich ; Thieblemont, Catherine ; Chiattone, Carlos Sergio ; Balasubramanian, Sriram ; Carey, Jodi ; Liu, Grace ; Shreeve, S Martin ; Sun, Steven ; Zhuang, Sen Hong ; Vermeulen, Jessica ; Staudt, Louis M ; Wilson, Wyndham

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1285-1295 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Treatment of high‐risk follicular lymphoma
Treatment of high‐risk follicular lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of high‐risk follicular lymphoma

Jurczak, Wojciech

HemaSphere, 2019-06, Vol.3 (Suppl), p.85-87 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
5
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Gopal, Ajay K ; Kahl, Brad S ; de Vos, Sven ; Wagner-Johnston, Nina D ; Schuster, Stephen J ; Jurczak, Wojciech J ; Flinn, Ian W ; Flowers, Christopher R ; Martin, Peter ; Viardot, Andreas ; Blum, Kristie A ; Goy, Andre H ; Davies, Andrew J ; Zinzani, Pier Luigi ; Dreyling, Martin ; Johnson, Dave ; Miller, Langdon L ; Holes, Leanne ; Li, Daniel ; Dansey, Roger D ; Godfrey, Wayne R ; Salles, Gilles A

The New England journal of medicine, 2014-03, Vol.370 (11), p.1008-1018 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Stilgenbauer, Stephan, Prof ; Eichhorst, Barbara, Prof ; Schetelig, Johannes, Prof ; Coutre, Steven, Prof ; Seymour, John F, Prof ; Munir, Talha, Prof ; Puvvada, Soham D, MD ; Wendtner, Clemens-Martin, Prof ; Roberts, Andrew W, Prof ; Jurczak, Wojciech, Prof ; Mulligan, Stephen P, Prof ; Böttcher, Sebastian, MD ; Mobasher, Mehrdad, MD ; Zhu, Ming, PhD ; Desai, Monali, MD ; Chyla, Brenda, PhD ; Verdugo, Maria, MD ; Enschede, Sari Heitner, MD ; Cerri, Elisa, MD ; Humerickhouse, Rod, MD ; Gordon, Gary, MD ; Hallek, Michael, Prof ; Wierda, William G, MD

The lancet oncology, 2016-06, Vol.17 (6), p.768-778 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Wang, Michael ; Rule, Simon ; Zinzani, Pier Luigi ; Goy, Andre ; Casasnovas, Olivier ; Smith, Stephen D ; Damaj, Gandhi ; Doorduijn, Jeanette ; Lamy, Thierry ; Morschhauser, Franck ; Panizo, Carlos ; Shah, Bijal ; Davies, Andrew ; Eek, Richard ; Dupuis, Jehan ; Jacobsen, Eric ; Kater, Arnon P ; Le Gouill, Steven ; Oberic, Lucie ; Robak, Taduesz ; Covey, Todd ; Dua, Richa ; Hamdy, Ahmed ; Huang, Xin ; Izumi, Raquel ; Patel, Priti ; Rothbaum, Wayne ; Slatter, J Greg ; Jurczak, Wojciech

The Lancet (British edition), 2018-02, Vol.391 (10121), p.659-667 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia

Sharman, Jeff P ; Egyed, Miklos ; Jurczak, Wojciech ; Skarbnik, Alan ; Pagel, John M ; Flinn, Ian W ; Kamdar, Manali ; Munir, Talha ; Walewska, Renata ; Corbett, Gillian ; Fogliatto, Laura Maria ; Herishanu, Yair ; Banerji, Versha ; Coutre, Steven ; Follows, George ; Walker, Patricia ; Karlsson, Karin ; Ghia, Paolo ; Janssens, Ann ; Cymbalista, Florence ; Woyach, Jennifer A ; Ferrant, Emmanuelle ; Wierda, William G ; Munugalavadla, Veerendra ; Yu, Ting ; Wang, Min Hui ; Byrd, John C

Leukemia, 2022-04, Vol.36 (4), p.1171-1175 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Wang, Michael L ; Rule, Simon ; Martin, Peter ; Goy, Andre ; Auer, Rebecca ; Kahl, Brad S ; Jurczak, Wojciech ; Advani, Ranjana H ; Romaguera, Jorge E ; Williams, Michael E ; Barrientos, Jacqueline C ; Chmielowska, Ewa ; Radford, John ; Stilgenbauer, Stephan ; Dreyling, Martin ; Jedrzejczak, Wieslaw Wiktor ; Johnson, Peter ; Spurgeon, Stephen E ; Li, Lei ; Zhang, Liang ; Newberry, Kate ; Ou, Zhishuo ; Cheng, Nancy ; Fang, Bingliang ; McGreivy, Jesse ; Clow, Fong ; Buggy, Joseph J ; Chang, Betty Y ; Beaupre, Darrin M ; Kunkel, Lori A ; Blum, Kristie A

The New England journal of medicine, 2013-08, Vol.369 (6), p.507-516 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Dreyling, Martin, Prof Dr ; Jurczak, Wojciech, MD ; Jerkeman, Mats, MD ; Silva, Rodrigo Santucci, MD ; Rusconi, Chiara, MD ; Trneny, Marek, Prof ; Offner, Fritz, MD ; Caballero, Dolores, MD ; Joao, Cristina, Prof ; Witzens-Harig, Mathias, Prof ; Hess, Georg, MD ; Bence-Bruckler, Isabelle, MD ; Cho, Seok-Goo, Prof ; Bothos, John, PhD ; Goldberg, Jenna D, MD ; Enny, Christopher, BS ; Traina, Shana, PhD ; Balasubramanian, Sriram, PhD ; Bandyopadhyay, Nibedita, PhD ; Sun, Steven, PhD ; Vermeulen, Jessica, MD ; Rizo, Aleksandra, MD ; Rule, Simon, Prof

The Lancet (British edition), 2016-02, Vol.387 (10020), p.770-778 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (474)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (495)
  2. Anais de Congresso  (4)
  3. Imagens  (1)
  4. Videos  (1)
  5. Conjunto de Dados  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2005  (8)
  2. 2005Até2008  (26)
  3. 2009Até2012  (27)
  4. 2013Até2017  (96)
  5. Após 2017  (346)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (501)
  2. Japonês  (20)
  3. Polonês  (5)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.